封面
市场调查报告书
商品编码
1705716

全球多组体学市场按产品/服务、类型、平台、应用、最终用途和地区划分

Global Multiomics Market, By Product & Service, By Type, By Platform, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2025 年全球多组体学市场规模估计为 24.7 亿美元,预计到 2032 年将达到 67.3 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 15.4%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 24.7亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 15.40% 2032年价值预测 67.3亿美元
数字。 2025年全球市场占有率多组体学市场份额(按地区)
全球多组学市场-IMG1

多体学是指一种综合体学方法,它结合了多种体学技术,包括基因组学、表观基因、转录组学、蛋白质组学和代谢体学,以全面了解生物系统。透过整合多种生物数据,与单体学方法相比,多体学有助于更深入了解分子机制、途径和网路。这使得研究人员能够更全面地整体情况生物过程和表型。随着研究人员意识到综合体学策略在研究健康和疾病方面的潜力,多体学市场正在快速成长。实验技术、生物资讯学工具和计算能力的进步正在进一步加速多体学在生物医学研究中的应用。

市场动态:

个人化医疗、药物发现和市场开发中体学的应用日益广泛,是预计在未来几年推动体学市场成长的一些关键因素。精准医疗越来越多地使用多体学方法根据患者的分子特征制定有效的个人化治疗方案。製药公司也利用多组体学来识别新的药物标靶和生物标记并开发精准药物。然而,大型复杂的多组体学资料集给资料整合和管理带来的挑战以及缺乏全面的分析工具是限制市场成长的一些因素。在预测期内,用户友好的数据分析解决方案的开发、数据处理工作流程的标准化以及体学数据存储库的建立可能会为多体学市场参与者创造丰厚的机会。

本研究的主要特点

  • 本报告对全球多组体学市场进行了详细分析,并以 2024 年为基准年,展示了预测期(2025-2032 年)的市场规模和年复合成长率(CAGR)。
  • 它还强调了各个领域的潜在收益成长机会,并说明了该市场的引人注目的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数,概述了全球多体学市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球多组体学市场报告针对该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过用于分析全球多体学市场的各种策略矩阵来做出决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
  • 影响分析
  • 主要亮点
  • 监管情景
  • 服务产品组合
  • PEST分析
  • 波特分析
  • 併购场景
  • 管道分析

第四章 全球多组体学市场-冠状病毒(COVID-19)大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 2020 年至 2032 年全球多组体学市场(按产品和服务)

  • 产品
  • 装置
  • 耗材
  • 软体
  • 服务

6. 2020 年至 2032 年全球多组体学市场(按类型)

  • 单细胞多组体学
  • 批量体学

7. 2020 年至 2032 年全球多元组体学市场(依平台划分)

  • 基因组学
  • 转录组学
  • 蛋白质体学
  • 代谢体学
  • 整合组体学平台

8. 全球多组体学市场(按应用划分),2020 年至 2032 年

  • 诊断
  • 药物研发
  • 个人化医疗
  • 农业基因组学
  • 其他(环境监测等)

9. 全球多组体学市场(依最终用途划分),2020 年至 2032 年

  • 製药和生物技术公司
  • 学术研究所
  • 临床研究组织(CRO)
  • 其他(医院、诊断中心等)

第 10 章。 2020 年至 2032 年按地区分類的全球多组体学市场

  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第十一章竞争格局

  • BD
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc
  • Danaher, PerkinElmer Inc.
  • Shimadzu Corporation
  • Bruker
  • QIAGEN
  • Agilent Technologies, Inc.
  • BGI

第十二章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6633

Global Multiomics Market is estimated to be valued at USD 2.47 Bn in 2025 and is expected to reach USD 6.73 Bn by 2032, growing at a compound annual growth rate (CAGR) of 15.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.47 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 15.40% 2032 Value Projection: USD 6.73 Bn
Figure. Global Multiomics Market Share (%), By Region 2025
Global Multiomics Market - IMG1

Multiomics refers to the integrated omics approach that combines diverse omic technologies such as genomics, epigenomics, transcriptomics, proteomics, and metabolomics to obtain comprehensive insights into biological systems. By integrating multiple layers of biological data, multiomics facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as researchers realize the potential of integrated omics strategies to study health and disease. Advancements in experimental techniques, bioinformatics tools, and computing power are further accelerating the application of multiomics in biomedical research.

Market Dynamics:

The growing adoption of multiomics in personalized medicine, drug discovery, and development are some of the key factors expected to drive the growth of the multiomics market in the coming years. Multiomics approaches are increasingly being used in personalized medicine to develop effective, individualized treatments based on a patient's molecular profile. Pharmaceutical companies are also leveraging multiomics to identify novel drug targets and biomarkers and develop precision therapeutics. However, data integration and management challenges posed by large and complex multiomics datasets as well as lack of comprehensive analytical tools are some of the factors expected to restrain the market growth. Development of user-friendly data analysis solutions, standardization of data processing workflows, and establishment of omics data repositories could create lucrative opportunities for multiomics market players over the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global multiomics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global multiomics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include BD, Thermo Fisher Scientific Inc., Illumina, Inc, Danaher, PerkinElmer Inc., Shimadzu Corporation, Bruker, QIAGEN, Agilent Technologies, Inc., and BGI.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global multiomics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiomics market.

Detailed Segmentation:

  • Global Multiomics Market, By Product & Service
    • Products
    • Instruments
    • Consumables
    • Software
    • Services
  • Global Multiomics Market, By Type
    • Single-cell Multiomics
    • Bulk Multiomics
  • Global Multiomics Market, By Platform
    • Genomics
    • Transcriptomics
    • Proteomics
    • Metabolomics
    • Integrated Omics Platforms
  • Global Multiomics Market, By Application
    • Diagnostics
    • Drug Discovery and Development
    • Personalized Medicine
    • AgriGenomics
    • Others (Environmental Monitoring, etc.)
  • Global Multiomics Market, By End User
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutes
    • Clinical Research Organizations (CROs)
    • Others (Hospitals and Diagnostic Centers, etc.)
  • Global Multiomics Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles
    • BD
    • Thermo Fisher Scientific Inc.
    • Illumina, Inc
    • Danaher, PerkinElmer Inc.
    • Shimadzu Corporation
    • Bruker
    • QIAGEN
    • Agilent Technologies, Inc.
    • BGI

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Multiomics Market, By Product & Service
    • Global Multiomics Market, By Type
    • Global Multiomics Market, By Platform
    • Global Multiomics Market, By Application
    • Global Multiomics Market, By End User
    • Global Multiomics Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing usage of multiomics in personalized medicine
    • Growing investment in and funding of multiomics research
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Service Offering Portfolio
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Pipeline Analysis

4. Global Multiomics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Multiomics Market, By Product & Service, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Instruments
  • Consumables
  • Software
  • Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

6. Global Multiomics Market, By Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Single-cell Multiomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Bulk Multiomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

7. Global Multiomics Market, By Platform, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Transcriptomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Metabolomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Integrated Omics Platforms
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

8. Global Multiomics Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Personalized Medicine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • AgriGenomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others (Environmental Monitoring, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

9. Global Multiomics Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Academic and Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Clinical Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
  • Others (Hospitals and Diagnostic Centers, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)

10. Global Multiomics Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021 - 2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product & Service, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Platform, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020-2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • BD
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Illumina, Inc
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Danaher, PerkinElmer Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Shimadzu Corporation
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Bruker
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Agilent Technologies, Inc.
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • BGI
    • Company Highlights
    • Product & Service Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us